SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401708-21-000031
Filing Date
2021-03-01
Accepted
2021-03-01 16:07:24
Documents
16
Period of Report
2021-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K nstg-20210301.htm   iXBRL 8-K 37303
2 EX-99.1 nstg-4q208kex991.htm EX-99.1 215003
8 LOGO nstg-logoa061.jpg GRAPHIC 29107
  Complete submission text file 0001401708-21-000031.txt   454240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nstg-20210301.xsd EX-101.SCH 2467
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nstg-20210301_cal.xml EX-101.CAL 750
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nstg-20210301_def.xml EX-101.DEF 1695
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nstg-20210301_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nstg-20210301_pre.xml EX-101.PRE 12686
9 EXTRACTED XBRL INSTANCE DOCUMENT nstg-20210301_htm.xml XML 10853
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

IRS No.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35980 | Film No.: 21697745
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences